Printed and electronic material, namely manuals, pamphlets and brochures, all relating to mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products.

Financial, advisory and investment services, namely the structuring, sale, distribution, management and administration of investments, namely mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products; (2) Financial products services namely brokerage, sales, advisory, distribution, administration, management, accounting, custodial and trustee services for mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products.

Toiletries, namely, body deodorant, shower gel, body wash, facial cleanser, face scrub, face wash, hand wash, preparations for the care of the skin, body mist spray, make-up concealer spot sticks, moisturisers, body lotion, body moisturiser, facial moisturiser, shaving gel, shaving oil, shaving foam, shaving spritz, shaving soap, pumice-stones, after-shave, after-shave gel, after-shave balm, hair removal preparations and creams, depilatory preparations, depilatory wax, hair-care preparations, shampoo, conditioner, hair gel, hair spritz, hairspray, perfumery, toilet waters (eau de toilette), dentifrices; essential oils for personal use; cosmetics; cutting and edged tools and implements, all being hand operated; razors; safety razors; dry shavers; blades for razors; razor blade dispensers; cases for razors and for dry shavers; all purposes scissors, hair cutting scissors, nail scissors; electric shavers.

Printed and electronic material, namely manuals, pamphlets and brochures, all relating to mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products.

Financial, advisory and investment services, namely the structuring, sale, distribution, management and administration of investments, namely mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products; (2) Financial products services namely brokerage, sales, advisory, distribution, administration, management, accounting, custodial and trustee services for mutual funds, commodity funds, pooled funds, hedge funds, exchange traded funds, closed-end funds, principal protected notes, wrap account products, securities and securities-based investment products.

Health product supplement for human consumption namely, St. John's Wort Extract , (2) Health product supplement for human consumption namely, flaxseed oil , (3) Health product supplement for human consumption namely, Valerian Extract , (4) Health production supplement for human consumption namely, Feverfew , (5) Health product supplement for human consumption namely, Black Coshosh , (6) Health product supplement for human consumption namely, Lysine (L-Lysine dthydrochoride) , (7) Health product supplement for human consumption namely, Vitamin D (Synthetic Vitamin D3) , (8) Health product supplement for human consumption namely, Chondroitin Sulfate , (9) Health product supplement for human consumption namely, 5-HTP (5-Hydroxytryptophan) , (10) Health product supplement for human consumption namely, Salmon Oil , (11) Health product supplement for human consumption namely, Seal Oil , (12) Health product supplement for human consumption namely, Chromium , (13) Health product supplement for human consumption namely, Green tea extract , (14) Health product supplement for human consumption namely, Vitamin C , (15) Health product supplement for human consumption namely, MSN (methylsulfonylmethane) , (16) Health product supplement for human consumption namely, Garlic Extract , (17) Health product supplement for human consumption namely, Selenium , (18) Health product supplement for human consumption namely, Milk Thistle Extract , (19) Health product supplement for human consumption namely, Glucosamine , (20) Health product supplement for human consumption namely, Coenzyme Q10 , (21) Health product supplement for human consumption namely, Evening Primrose Oil , (22) Health product supplement for human consumption namely, Echinacea Extract , (23) Health product supplement for human consumption namely, Saw Palmetto Extract , (24) Health product supplement for human consumption namely, Ginkgo Biloba Extract , (25) Health product supplement for human consumption namely, Cranberry Extract.

Industrial oils and greases; industrial lubricants; industrial lubricating oils and greases.

Theft prevention and security devices, namely cable locks, electronic sensors, locking device to be placed around the neck and lip or cap of a bottle to prevent the theft of the bottle or its content, hard tags, both alarming and non-alarming; alarming and non-alarming display fixtures to provide security against theft at retail stores, and lockable storage and display containers, both alarming and non-alarming, media security containers for DVD’s, cassettes, CD’s, video tapes, game cartridges and disks, both alarming and non-alarming, to prevent theft of merchandise in retail stores.

Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes in the field of Alpha-1 Antitrypsin Deficiency; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency

Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes

Downloadable electronic publications in the nature of informational and educational materials, namely booklets, in the field of Alpha-1 Antitrypsin Deficiency; downloadable multimedia files containing artwork, text, audio and video in the field of Alpha-1 Antitrypsin Deficiency; pre-recorded electronic media, namely CDs, DVDs, thumb drives and video tapes; printed informational and educational materials, namely, booklets and reference guides, in the field of Alpha-1 Antitrypsin Deficiency

Charitable services, namely, providing financial support for clinical research to improve the lives of individuals affected by Alpha-1 Antitrypsin Deficiency; education services, namely, providing classes, seminars, and workshops in the field Alpha-1 Antitrypsin Deficiency; providing on-line publications in the nature of guides and newsletters in the field of Alpha-1 Antitrypsin Deficiency; training of study staff in the field of Alpha-1 Antitrypsin Deficiency and clinical trials; providing medical and scientific research information in the field of Alpha-1 Antitrypsin Deficiency; consultation services in the field of facilitating and conducting clinical trials involving human subjects of new treatment options for individuals affected by Alpha-1 Antitrypsin Deficiency in the nature of identifying qualified study sites and researchers and encouraging study enrollment; providing quality assurance services in the field of clinical trials by generating and monitoring study data and documentation thereof for quality assurance purposes; health care services, namely, disease management for individuals affected by Alpha-1 Antitrypsin Deficiency; providing support and assistance services to inform individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing links to the web sites of others featuring information about the diagnosis, management and treatment of Alpha-1 Antitrypsin Deficiency; providing health and medical care information to individuals affected by Alpha-1 Antitrypsin Deficiency about the range of possible diagnoses and therapies to improve the quality of their lives; providing support and assistance, namely counselling services, to individuals affected by Alpha-1 Antitrypsin Deficiency; identifying qualified study sites, namely, inspection of laboratory research facilities for safety purposes

Downloadable electronic publications in the nature of informational and educational materials, namely newsletters, in the field of Alpha-1 Antitrypsin Deficiency; printed informational and educational materials, namely, newsletters, in the field of Alpha-1 Antitrypsin Deficiency.

Cellular telephones.

Telecommunications services, namely, wireless voice and data transmission, two way wireless transmission of email and text between wireless telecommunication terminals and computers, and providing multiple-user access to a global computer network.